VR headset vs. pills: which beats social anxiety in teens?
NCT ID NCT07192367
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study compares two treatments for social anxiety in adolescents and young adults: virtual reality exposure therapy and the medication sertraline. Fifty-six participants will be randomly assigned to either VR sessions that simulate anxiety-provoking social situations or daily sertraline pills. The goal is to see which approach reduces anxiety symptoms and improves daily life more effectively.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Virtual Reality Exposure Therapy and Sertraline
- What this could lead to
- If successful, this could show that virtual reality therapy is as good as or better than medication for treating social anxiety in teens.
- What could go wrong
- This is a small, early-phase study with only 56 participants, so results may not apply to everyone. The virtual reality approach may not work for all types of social anxiety.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 4
Runs after approval, following long-term safety and how well the treatment works in everyday use.
- Participants
-
About 56 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Nov 2024
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
12 to 17 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * RESEARCH ARM: 1. Applied to Kocaeli University Child and Adolescent Psychiatry Outpatient Clinic 2. Have normal intelligence based on clinical observation 3. Be between 12 and 17 years of age 4. Have a diagnosis of SAD 5. Have refused medication recommended for SAD 6. For SAD; are not currently receiving medical treatment 7. Have received written consent to participate in the study from them and/or their first-degree relatives authorized to make decisions about them 8. Have volunteered to participate in the study through an invitation poster presentation CONTROL ARM: 1 Applied to Kocaeli University Child and Adolescent Psychiatry Outpatient Clinic 2. Have normal intelligence based on clinical observation 3. Be between 12 and 17 years of age 4. Have a diagnosis of SAD 5. Have refused medication recommended for SAD 6. For SAD; are not currently receiving medical treatment 7. Have obtained written informed consent to participate in the study from them and/or their first-degree relatives authorized to make decisions about them 8. Have volunteered to participate in the study through an invitation poster presentation CONTROL ARM: 1 Applied to Kocaeli University Child and Adolescent Psychiatry Outpatient Clinic 2. Have normal intelligence based on clinical observation 3. Be between 12 and 17 years of age 4. Have a diagnosis of SAD 5. For SAD; Not currently receiving medical treatment 6. Volunteer 7. Written consent for participation in the study must be obtained from the patient and/or their first-degree relative authorized to make decisions about them. 8\. Accept sertraline treatment, routinely used in outpatient clinic follow-ups for SAD, and volunteer for the study. Exclusion Criteria: RESEARCH ARM: 1. Substance use disorder 2. Schizophrenia and bipolar disorder 3. Autism spectrum disorder 4. Cognitive disability 5. Neurological disorder 6. Balance disorder 7. Patients who have received SSRI treatment for SAD in the last 6 months CONTROL ARM: 1. Substance use disorder 2. Schizophrenia and bipolar disorder 3. Autism spectrum disorder 4. Cognitive disability 5. Patients who have received SSRI treatment for SAD within the last 6 months -
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Social anxiety disorder are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Kocaeli University Hospital - Department of Child and Adolescent Psychiatry
RECRUITINGKocaeli, 41000, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a computer game rewire anxious Kids' brains?
- Can tailored brain stimulation quiet anxiety that drugs Can't?
- Can meditation rewire the anxious social brain?
- One-Size-Fits-All anxiety therapy may be a thing of the past
- Ear-Zapping device may tame social anxiety — trial puts it to the test
- Can an AI coach help therapists treat depression and anxiety online?